Surfactant Prefiltration for Emulsion Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Pharmaceutical, nutraceutical, and cosmetic compositions containing surfactants often undergo degradation, leading to unwanted impurities such as carbonyl compounds, which affect the quality and shelf-life of products like emulsion-based vaccine adjuvants.
Innovation Solution
Pre-processing surfactants through size filtration, specifically using filters with pore sizes between 5-50 μm, to remove aggregates and reduce carbonyl impurities, thereby enhancing the stability and purity of surfactant-containing compositions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If surfactants are used in pharmaceutical compositions, then emulsification and stability are improved, but degradation to carbonyl compounds occurs reducing shelf-life
Solution Approach 1:
The patent applies preliminary action by pre-filtering the surfactant through a 0.2-2.0 μm filter before incorporating it into the pharmaceutical composition. This pre-processing step removes aggregates and degradation products from the surfactant beforehand, preventing them from catalyzing further degradation in the final formulation, thus extending shelf-life while maintaining emulsion stability
2Ease of manufacture
If surfactant aggregates are present, then formulation is simplified, but product quality and purity are reduced
Solution Approach 1:
The patent applies the extraction principle by removing surfactant aggregates through filtration before formulation. The 0.2-2.0 μm filter specifically extracts and removes aggregate structures from the surfactant solution, separating the harmful aggregated form from the useful monomeric surfactant molecules, thereby improving product purity without complicating the overall formulation process
3Ease of manufacture
If standard filtration is used, then manufacturing is simple, but carbonyl impurities remain affecting quality
Solution Approach 1:
The patent applies parameter changes by specifying a particular pore size range (0.2-2.0 μm) for the filtration step. This precise parameter selection optimizes the balance between removing carbonyl-containing aggregates and maintaining manufacturing simplicity. The specific pore size acts as a critical parameter that enables effective impurity removal while keeping the process straightforward and scalable
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pre-filtration process results in surfactant preparations with lower carbonyl levels and fewer aggregates, improving the stability and extending the shelf-life of emulsion-based products, such as oil-in-water emulsions, by up to 100% compared to unfiltered counterparts.
Implementation Method 1
prefiltration of a surfactant with a filter having an average pore size of 5-50 micron
Data Source
AI summary
Improved methods for the manufacture of pharmaceutical compositions comprising at least one surfactant, involving prefiltration of the surfactant prior to formulation into final products.